Grants to Support Investigator-Initiated Early-Phase Clinical Trials in Indiana (USA)
GrantID: 64183
Grant Funding Amount Low: $250,000
Deadline: October 2, 2026
Grant Amount High: $1,515,000
Summary
The grant aims to accelerate the development of innovative treatments and diagnostic tools for heart, lung, blood, and sleep (HLBS) conditions. The program seeks to catalyze breakthroughs in HLBS research, ultimately improving patient outcomes and advancing medical knowledge...
Eligible applicants in Indiana with a demonstrated commitment to Research & Evaluation are encouraged to consider this funding opportunity. To identify additional grants aligned with your needs, visit The Grant Portal and utilize the Search Grant tool for tailored results.
Eligible Regions
Interests
Eligible Requirements
